This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through February 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
Zacks News
ETFs to Make the Most of the M&A Comeback
by Sweta Killa
After several quiet years, global M&A activity gathered steam early in 2024 following a flurry of deals. The deal value surged 55% year over year to $425 billion, signaling a robust revival in the sector.
What Lies Ahead of M&A ETFs in 2024?
by Sanghamitra Saha
As we move into 2024, optimism around a comeback year for deal-making exists. However, the M&A landscape continues to evolve, with private equity becoming an increasingly attractive option for companies and investors seeking smoother and more predictable exits.
M&A ETF Beats S&P 500 in 2022: What Awaits in 2023?
by Sanghamitra Saha
Dealmaking in the global M&A market has been somewhat muted in 2022 due to a global growth slowdown.
After a Solid 2021, Can M&A & Its ETF Soar in 2022?
by Sanghamitra Saha
U.S. M&A activity totaled $2.5 trillion in 2021, breaching the 2015 peak. Though rising rate worries and a tumbling stock market are drags on the M&A activity in 2022, cash cushion and some emerging trends may buoy this corporate activity this year as well.
Vaccination & Economic Recovery to Boost These ETFs
by Sanghamitra Saha
With COVID-19 vaccination taking momentum, the outlook for large U.S. companies' corporate actions is looking bright.
How to Trade USFDA's EUA to J&J Vaccine With ETFs
by Sanghamitra Saha
On Feb 27, the United States sanctioned Johnson & Johnson's COVID-19 vaccine for emergency use, giving the nation a third vaccine to fight the outbreak, after BioNTech/Pfizer and Moderna.
ETF Areas to Win/Lose With Biden on the Verge of Victory
by Sanghamitra Saha
Though the counting process for the U.S. election outcome is still on, the prospect of a Joe Biden presidency marked by a divided Congress is rife.
M&A ETF (MNA) Hits New 52-Week High
by Sweta Killa
This M&A ETF hits a new 52-week high. Are more gains in store for this ETF?
After a Solid Q3, Can M&A ETF Soar in Q4?
by Sanghamitra Saha
It was a great Q3 for mergers and acquisitions (M&A) that were on hold amid the peak of coronavirus-led lockdowns.
Winning ETF Strategies for Q4
by Sanghamitra Saha
The October-December period will revolve around the events like holiday season, presidential election, vaccine trials and stimulus talks.